The current treatment approach for systemic lupus erythematosus (SLE), as outlined in the
recommendations by international medical associations including EULAR and the ACR, is …

Objectives To develop recommendations for monitoring patients with systemic lupus
erythematosus (SLE) in clinical practice and observational studies and to develop a …

Background and objectives: The value of a complete remission in severe lupus nephritis is
well known but little is known about the impact of a partial remission in this patient …

Objective Immunosuppressive agents have become the standard of therapy for proliferative
lupus nephritis, but some patients may relapse after discontinuing treatment. We reviewed …

Patients affected with systemic lupus erythematosus (SLE) display poor-long term prognosis
and increased mortality in respect of general population. This may be due to continuous …

Around 1980 antinuclear antibody testing became widely used in routine laboratory practice
leading to a tapering in the lag time between SLE onset and diagnosis. Since then nothing …

Remission, relapse, and re-remission of proliferative lupus nephritis treated with
cyclophosphamide. Background Long-term intravenous cyclophosphamide (IVC) in …

Radboud eight years ago because of general fatigue, arthralgias, myalgias, facial rash, and
a fever (38.1 C). Her general physician had prescribed salicylates and later nonsteroidal anti …

Abstract Purpose of Review Discuss the prognostic significance of kidney flares in patients
with lupus nephritis, associated risk factors, and possible preventative strategies. Recent …

Objective To study the incidence, predictors, and outcome of renal flares after successful
cyclophosphamide (CYC) treatment for diffuse proliferative glomerulonephritis (DPGN) in …